Experimental Arrowhead RNAi drug hints at Alzheimer’s benefit

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 14 Oct, 15:54 UTC

In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.

science

Sources

• T2Experimental Arrowhead RNAi drug hints at Alzheimer’s benefitBioPharma Dive / Healthcare Dive / MedTech Dive14 Oct, 15:54